Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05434637 · ClinicalTrials.gov registry record · NA
Somatosensory Tinnitus RCT
A NA study of Tinnitus, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05434637: Recruiting NA study of Tinnitus, sponsored by VA Office of Research and Development.
NCT05434637 is a NA study of Tinnitus that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 72 participants, below the 12,617-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05434637, a NA study of Tinnitus, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about a type of tinnitus (ringing in the ears) known as "somatosensory tinnitus." This type of tinnitus is suspected when the tinnitus perception changes following head and/or neck movements. This study is also exploring a possible way to treat somatosensory tinnitus.
Primary Outcome
The Tinnitus Functional Index (TFI) is a 25-item questionnaire that evaluates treatment responsiveness (i.e., changes in functional effects of tinnitus over time). Total possible score ranges from 0-to-100 (scores \>25 indicate tinnitus is a significant problem).
Conditions Studied
Interventions
- OTHER Physical Therapy
- OTHER Sound-based Therapy
- OTHER Combination Therapy
Study Locations (1)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05434637 shows while recruiting
NCT05434637 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 12,617-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 3 interventions - of which Physical Therapy is the first listed.
NCT05434637 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05434637 about?
NCT05434637 is a clinical study titled "Somatosensory Tinnitus RCT". The purpose of this study is to learn more about a type of tinnitus (ringing in the ears) known as "somatosensory tinnitus." This type of tinnitus is suspected when the tinnitus perception changes following head and/or neck movements. This study is also exploring a possible way to treat somatosensor...
What is the current status of trial NCT05434637?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-11-01. Estimated completion is 2027-09-30.
What conditions does trial NCT05434637 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT05434637?
The interventions under investigation include: Physical Therapy (OTHER), Sound-based Therapy (OTHER), Combination Therapy (OTHER).
Who is sponsoring clinical trial NCT05434637?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05434637 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05434637's enrollment target sits among peer trials
72 14th of 24 higher than 11 of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
-
External Therapy for Tinnitus Management
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
-
Notched Noise Therapy for Suppression of Tinnitus
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI